Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early microglia progenitors colonize the embryonic CNS via integrin-mediated migration from the pial surface.

Developmental cell·2025
Same author

Monitoring and orthogonal control of agrobacteria in Nicotiana benthamiana leaves.

Plant biotechnology journal·2025
Same author

Extrasinusoidal macrophages are a distinct subset of immunologically active dural macrophages.

Science immunology·2024
Same author

Structural and functional snapshots of a broad-specificity endoglucanase from Thermogutta terrifontis for biomass saccharification.

Archives of biochemistry and biophysics·2024
Same author

Comparative analysis of the Squamosa Promoter Binding-Like (SPL) gene family in Nicotiana benthamiana and Nicotiana tabacum.

Plant science : an international journal of experimental plant biology·2023
Same author

Author Correction: Specification of CNS macrophage subsets occurs postnatally in defined niches.

Nature·2022
Same journal

Inflammatory Indices and Pediatric Emergence Delirium: Predictive Signal or Statistical Artifact?

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 1-One Center's 15 Year Evolution in Eligibility, Utilization, Efficiency, and Outcomes.

Paediatric anaesthesia·2026
Same journal

Retrospective Evaluation of an Artificial Intelligence-Assisted Video Laryngoscope System for Tracheal Intubation in Infants and Neonates.

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 2-One Center's 15 Year Experience Improving Quality and Safety Outcomes.

Paediatric anaesthesia·2026
Same journal

Response to: Reliability of the Pediatric Specific ASA Physical Status Classification.

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 4-Evolving Solutions in Pediatric Ambulatory Anesthesia: From Registries to a Learning Health System Approach.

Paediatric anaesthesia·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Risk in pediatric anesthesia.

Neil Paterson1, Peter Waterhouse

  • 1Royal Children's Hospital, Brisbane, Queensland, Australia. neil_paterson@health.qld.gov.au

Paediatric Anaesthesia
|August 21, 2010
PubMed
Summary
This summary is machine-generated.

Pediatric anesthesia risks are classified as minor or major, with major events like cardiac arrest being rare. Both risk types are most common in young children, especially those with existing health issues.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Experiment Videos

Last Updated: Jun 10, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Patient Safety

Background:

  • Pediatric anesthesia carries risks that require careful classification and understanding.
  • Minor and major morbidities represent distinct categories of adverse events.
  • Identifying at-risk populations is crucial for improving safety outcomes.

Purpose of the Study:

  • To classify risks associated with pediatric anesthesia.
  • To identify the most common patient demographics and conditions associated with anesthesia-related morbidity.
  • To establish a foundation for risk reduction strategies in pediatric anesthesia.

Main Methods:

  • Classification of pediatric anesthesia risks into minor and major categories.
  • Utilizing clinical audits for minor morbidity assessment.
  • Employing large-scale clinical studies and malpractice claim reviews for major morbidity assessment.

Main Results:

  • Major pediatric anesthesia morbidity includes severe outcomes such as cardiac arrest, brain damage, and death.
  • Minor morbidity can be effectively evaluated through clinical audits.
  • Both minor and major anesthesia-related complications predominantly affect infants and children under three years old, particularly those with significant co-morbidities.

Conclusions:

  • Understanding pediatric anesthesia risk profiles is essential for implementing effective risk reduction measures.
  • Young children, especially those with comorbidities, represent a high-risk group for anesthesia-related complications.
  • A dual approach using audits and large-scale studies is necessary for comprehensive risk assessment.